Ampersand Biomedicines (Series B)

Funding Details
Awarder
Inbox
Date Award
March 19, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Traction
The company announced the advancement of two lead programs and a second discovery partnership in obesity.
Company Description
Ampersand Biomedicines is a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else.
Market
Pharmaceuticals
Location
Boston, MA, USA
Coinvestors
Flagship Pioneering, Eli Lilly & Company

Links
Back to Home Back to Biotechnology Deals View Funding Announcement